“…F0414 is a benzimidazole compound with no biological activities reported. There has been a lot of benzimidazole compounds used in clinic, which exhibited various properties, such as anti-tumor, anti-viral, anti-bacterial, anti-fungal, and anti-metabolic syndrome ( He et al, 2019 ; Shi et al, 2019 ; Singh et al, 2019 ; Tharmalingam et al, 2019 ). For example, pracinostat, a novel benzimidazole-based histone deacetylase inhibitor, has been identified as a potential agent for treating breast cancer ( Chen et al, 2020 ).…”